Outcomes of hepatocellular carcinoma beyond the UCSF criteria after upfront living donor liver transplant and down-staging

被引：0
|
作者：
Wong, T. [1 ]
Mehta, N. [2 ]
Chan, W. O. [2 ]
Yao, F. [2 ]
Lo, C. M. [1 ]
机构：
[1] Univ Hong Kong, Surg, Hong Kong, Peoples R China
[2] Univ Calif San Francisco, Med, San Francisco, CA 94143 USA
来源：
TRANSPLANTATION | 2022年 / 106卷 / 8S期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
O-087
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [41] Living Donor Liver Transplant for Hepatocellular Carcinoma
    Vijay Subramanian
    William Chapman
    Annals of Surgical Oncology, 2019, 26 : 1594 - 1595
  • [42] LIVING DONOR LIVER TRANSPLANTATION FOR ADVANCED HEPATOCELLULAR CARCINOMA: BEYOND MILAN CRITERIA
    Kim, Dong-Goo
    Lee, Keung-Keun
    Park, Jung-Hyun
    LIVER TRANSPLANTATION, 2009, 15 (07) : S198 - S199
  • [43] Living Donor Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Is It Justified?
    El-Meteini, Mahmoud
    Fathy, Mohamed
    Bahaa, Mohamed
    Abdelaal, Amr
    Mukhtar, Ahmed
    Abdelwahab, Sameh
    Shaker, Mohamed
    El-Dorry, Ahmed
    El-Moayeri, Magda
    Hamza, Alaa
    Safwat, Wael
    Refaie, Rasha
    LIVER TRANSPLANTATION, 2010, 16 (06) : S237 - S238
  • [44] Radiotherapy as Down Staging Treatment to Living Donor Liver Transplantation for Hepatocellular Carcinoma.
    Choi, J.
    Park, J.
    Kim, S.
    Lee, K.
    Rhu, J.
    Gil, E.
    Na, B.
    Oh, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 700 - 700
  • [45] Radiotherapy as Down Staging Treatment to Living Donor Liver Transplantation for Hepatocellular Carcinoma.
    Choi, J.
    Park, J.
    Kim, S.
    Lee, K.
    Rhu, J.
    Gil, E.
    Na, B.
    Oh, D.
    TRANSPLANTATION, 2014, 98 : 700 - 700
  • [46] Multicenter Study of Down-staging of Hepatocellular Carcinoma (HCC) to within Milan Criteria before Liver Transplantation (LT)
    Mehta, Neil
    Guy, Jennifer
    Frenette, Catherine T.
    Sarkar, Monika
    Osorio, Robert W.
    Minteer, William B.
    Roberts, John P.
    Yao, Francis Y.
    HEPATOLOGY, 2014, 60 : 253A - 254A
  • [47] Model to predict recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria
    Cho, Yuri
    Lee, Jeong-Hoon
    Cho, Eun Ju
    Lee, Donghyeon
    Yoo, Jeong-Ju
    Lee, Minjong
    Cho, Young Youn
    Yu, Su Jong
    Yi, Nam-Joon
    Lee, Kwang-Woong
    Kim, Seong Hoon
    Kim, Jong Man
    Joh, Jae Won
    Lee, June Sung
    Kim, Yoon Jun
    Suh, Kyung-Suk
    Yoon, Jung-Hwan
    HEPATOLOGY, 2015, 62 : 412A - 412A
  • [48] MODEL TO PREDICT RECURRENCE AFTER LIVING DONOR LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA BEYOND THE MILAN CRITERIA
    Lee, J. -H.
    Cho, Y.
    Lee, D. H.
    Lee, Y. B.
    Yu, S. J.
    Yi, N. -J.
    Lee, K. -W.
    Kim, S. H.
    Kim, Y. J.
    Yoon, J. -H.
    Suh, K. -S.
    Lee, H. -S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S372 - S373
  • [49] Longer term results for hepatocellular carcinoma (HCC) liver transplant (LT) recipients: Down-staging has benefit
    Harper, Ann M.
    Edwards, Erick B.
    Freeman, Richard B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 259 - 259
  • [50] Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
    Yonemura, Yusuke
    Yoshizumi, Tomoharu
    Inokuchi, Shoichi
    Kosai-Fujimoto, Yukiko
    Harada, Noboru
    Itoh, Shinji
    Toshima, Takeo
    Takeishi, Kazuki
    Yoshiya, Shohei
    Mori, Masaki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2020, 4 (04): : 413 - 421
12345